LONDON BROKER RATINGS: Stifel raises Rentokil to 'buy' from 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 297.90p on 07-10-2026 at 17:45:10 |
|---|---|
| Change | -1.10p -0.37% |
| Buy | 297.60p |
| Sell | 297.40p |
| Last Trade: | Unknown 4,411.00 at 297.90p |
| Day's Volume: | 8,983,550 |
| Last Close: | 297.90p |
| Open: | 297.50p |
| ISIN: | GB00B082RF11 |
| Day's Range | 295.90p - 301.30p |
| 52wk Range: | 293.50p - 506.80p |
| Market Capitalisation: | £7.50b |
| VWAP: | 298.36104p |
| Shares in Issue: | 2.52b |
Rentokil Initial (RTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 4,411 | 297.90p | OTC Trade |
16:35:16 - 07-Oct-26 |
| Buy* | 2,475,130 | 297.90p | Suspected BUY Trade |
16:35:16 - 07-Oct-26 |
| Buy* | 200 | 297.505p | SI Trade |
16:29:54 - 07-Oct-26 |
| Buy* | 107 | 297.50p | Automatic Execution |
16:29:48 - 07-Oct-26 |
| Buy* | 6 | 297.50p | SI Trade |
16:29:36 - 07-Oct-26 |
| Buy* | 582 | 297.40p | Automatic Execution |
16:29:10 - 07-Oct-26 |
| Buy* | 1,836 | 297.40p | Automatic Execution |
16:29:10 - 07-Oct-26 |
| Buy* | 2,244 | 297.40p | SI Trade |
16:28:43 - 07-Oct-26 |
| Buy* | 4,252 | 297.40p | Automatic Execution |
16:28:43 - 07-Oct-26 |
| Sell* | 3,000 | 297.40p | Automatic Execution |
16:28:43 - 07-Oct-26 |
Rentokil Initial (RTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 11:15 am | RNS | Holding(s) in Company |
| 30th Sep 2026 10:25 am | RNS | Holding(s) in Company |
| 22nd Sep 2026 7:00 am | RNS | Sale of SOLitude Lake Management, LLC |
| 27th Aug 2026 3:00 pm | RNS | Interim Dividend – Pence Sterling Amount Payable |
| 13th Aug 2026 9:30 am | RNS | Organisational Changes & Leadership Appointments |
| 4th Aug 2026 10:30 am | RNS | Holding(s) in Company |
| 3rd Aug 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 16th Jul 2026 10:00 am | RNS | Director Declaration |
| 21st May 2026 7:00 am | RNS | Appointment of CEO, North America |